BEDMINSTER, N.J., April 10 /PRNewswire/ -- Clinsys Clinical Research, a therapeutically focused global contract research organization, today announced the launch of Clinsys ALTERNA, which utilizes its Global Project Solution(R) (Clinsys GPS(R)) to augment clinical resource services. The new division demonstrates Clinsys' commitment to aligning its service offerings with its sponsors' and the life sciences industry's continuously evolving staffing needs.
Clinsys ALTERNA provides customized Phase I-IV clinical trial alternative solutions to the conventional outsourcing model. The division is a core element of Clinsys GPS, a unique, highly effective and proven integrated project management solution that brings the sponsor and the Clinsys project teams together to collaborate and agree on all aspects of the clinical study- before, during and after-to ensure the project's success.
"Clinsys ALTERNA provides a targeted and flexible clinical resourcing model that adapts to best serve a sponsor's trial management needs," said David E. Williams, Chief Executive Officer of Clinsys. "We devoted the time and energy required to approach the evolution of resourcing in an innovative way that both maximizes efficiencies and decreases deliverable timelines."
Drawing on extensive clinical research experience, Clinsys ALTERNA delivers a custom-designed, time-sensitive clinical solution that enables sponsors to engage its services in site management, clinical monitoring, project management, drug safety, regulatory and medical writing on a contract basis. Clinsys ALTERNA combines therapeutic expertise, clinical screening, performance reviews, site references and global reach to offer clients the most dependable and comprehensive alternative approach to their trial needs. Visit clinsysalterna.com for more information.
About Clinsys Clinical Research, Inc.
Clinsys Clinical Research, Inc.(R), is a therapeutically focused
clinical research organization and a Jubilant Organosys company
headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh,
North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Noida and
Bangalore, India. Clinsys provides pharmaceutical, biotechnology and
medical device companies a broad range of clinical research services in
support of Phase I-IV drug development: project management, medical and
clinical monitoring, investigator and patient recruitment, site management,
biostatistics, data management, drug safety, quality assurance, regulatory
services and medical writing services. Clinsys has expertise in a wide
range of highly specialized therapeutic areas, including oncology,
cardiovascular, central nervous system, dermatology, respiratory and
allergy/immunology. Clinsys Clinical Research, Ltd., with operations in
Noida and Bangalore, India, provides extensive clinical research services
for Phase I-IV drug development, and operates a clinical pharmacology unit
performing bioavailability and bioequivalence studies as well as
bioanalytical sample analysis, clinical laboratory and pathology services.
Clinsys ALTERNA(TM) (clinsysalterna.com), a division of Clinsys Clinical
Research, Inc., partners with clients globally to provide customized Phase
I- IV clinical trial alternative solutions to the conventional outsourcing
model. For more information, visit clinsys.com.
Daniele De Leo
Vice President, Clinsys ALTERNA
Clinsys, Clinsys Clinical Research, Inc., Clinsys GPS and Global Project Solution are registered trademarks of Clinsys Clinical Research, Inc. Clinsys ALTERNA registration pending. (C) Copyright 2008 Clinsys Clinical Research, Inc. All rights reserved.
|SOURCE Clinsys Clinical Research, Inc.|
Copyright©2008 PR Newswire.
All rights reserved